Drug sensitivity and resistance testing identifies PLK1 inhibitors and gemcitabine as potent drugs for malignant peripheral nerve sheath tumors

• Matthias Kolberg, Jarle Bruun, Astrid Murumägi, John P. Mpindi, Christian H. Bergsland, Maren Høland, Ina A. Eilertsen, Stine A. Danielsen, Olli Kallioniemi, Ragnhild A. Lothe

• Molecular Oncology, July 2017, Wiley
• DOI: 10.1002/1878-0261.12086